Pharmanutra SpA (PHN.MI) stock: key figures, P/E, revenue and dividend

Consumer Staples · Italy · ISIN IT0005274094

Price
73.00 EUR
Market cap
701.90 m EUR
P/E (2025)
34.95
P/S (2025)
5.32
Dividend yield
1.64 %
Net margin
15.15 %
Return on equity (ROE)
28.03 %
Return on assets (ROA)
15.97 %

Pharmanutra SpA financials

Fiscal year20242025
Revenue116.00 m EUR132.00 m EUR
Gross profit90.00 m EUR102.00 m EUR
EBIT28.00 m EUR30.00 m EUR
Net income16.00 m EUR20.00 m EUR
Diluted EPS – continuing operations1.67 EUR2.09 EUR

Full history since 2015, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Pharmanutra SpA

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for muscle and joint recovery in physiotherapy and sports. The company also sells instrumentation and software for body bioimpedance analysis through agents, distributors, and online sales. Pharmanutra S.p.A. was founded in 2000 and is headquartered in Pisa, Italy.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.